In Medicare drug negotiations, Trump administration embraces a policy the GOP once despised

WASHINGTON — On Tuesday, the Trump administration celebrated drug price cuts it had secured through a Democrat-created program — despite Republicans’ longstanding antipathy toward the policy.

The Inflation Reduction Act, a 2022 law supported solely by Democrats and signed into law by then-President Biden, allowed the Trump administration to secure lower prices on 15 drugs for Medicare recipients, including popular GLP-1s like Wegovy and Ozempic.

Read the rest…